Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-04-10

Clinical Trial Update: Pharmacokinetics of Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder (HSDD) [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of Flibanserin in postmenopausal women with hypoactive sexual desire disorder, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flibanserin (Addyi) (Flibanserin)

Snippet

Sponsor: Sprout Pharmaceuticals, Inc | Conditions: Sexual Dysfunctions, Psychological | Phase 1 | Status: COMPLETED | Results posted: 2012-04-10